Bone disease in anorexia nervosa

Hormones

Volumn 13, Issue 1, 2014, Pages 38-56

  Dede, Anastasia D ^a   Lyritis, George P ^b   Tournis, Symeon ^c  

^a HIPPOKRATION HOSPITAL   (Greece)

^b Hellenic Osteoporosis Foundation   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Anorexia nervosa; Bone disease; Fractures

Indexed keywords

ADIPONECTIN; ALENDRONIC ACID; AMYLIN; BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; ETIDRONIC ACID; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 2; GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; INSULIN; LEPTIN; LIOTHYRONINE; MENATETRENONE; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE[1-34]; PEPTIDE YY; PLACEBO; PRASTERONE SULFATE; RECOMBINANT SOMATOMEDIN C; RISEDRONIC ACID; SOMATOMEDIN C; TESTOSTERONE; THYROTROPIN;

ANOREXIA NERVOSA; BODY COMPOSITION; BODY MASS; BONE DENSITY; BONE DISEASE; BONE MASS; BONE METABOLISM; BONE STRENGTH; BONE TURNOVER; CUSHING SYNDROME; DISEASE ASSOCIATION; DRUG SAFETY; FRACTURE; HOMEOSTASIS; HUMAN; HYPERCORTISOLISM; INSULIN SENSITIVITY; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; REVIEW; SEX DIFFERENCE; WNT SIGNALING PATHWAY; BONE; BONE DISEASES; COMPLICATION; FRACTURES, BONE; METABOLISM; PHYSIOLOGY;

ANOREXIA NERVOSA; BONE AND BONES; BONE DENSITY; BONE DISEASES; FRACTURES, BONE; HUMANS;

EID: 84899637728     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401319     Document Type: Review

References (208)

1. th edition
2. Smink FR, Van Hoeken D, Hoek HW, 2012 Epidemiology of eating disorders: Incidence, prevalence and mortality rates. Curr Psychiatry Rep 14: 406-414.
3. Hoek HW, Van Hoeken D, 2003 Review of the prevalence and incidence of eating disorders. Int J Eat Disord 34: 383-396.
4. Bulik CM, Sullivan PF, Tozzi F, Furberg H, Lichtenstein P, Pedersen NL, 2006 Prevalence, heritability and prospective risk factors for anorexia nervosa. Arch Gen Psychiatry 63: 305-312.
5. Herpertz-Dahlmann B, Seitz J, Konrad K, 2011 Aetiology of anorexia nervosa: from a "psychosomatic family model" to a neuropsychiatric disorder? Eur Arch Psychiatry Clin Neurosci 26: Suppl 2: 177-181.
6. Galusca B, Zouch M, Germain N, et al, 2008 Constitutional thinness:Unusual human phenotype of low bone quality. J Clin Endocrinol Metab 93: 110-117.
7. Woods SC, D'Alessio DA, 2008 Central control of body weight and appetite. J Clin Endocrinol Metab 93: Suppl 1: 37-50.
8. Eckert ED, Pomeroy C, Raymond N, Kohler PF, Thuras P, Bowers CY, 1998 Leptin in anorexia nervosa. J Clin Endocrinol Metab 83: 791-795.
9. Misra M, Miller KK, Almazan C, et al, 2004 Hormonal and body composition predictors of soluble leptin receptor, leptin and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J Clin Endocrinol Metab 89: 3486-3495.
10. Audi L, Mantzoros CS, Vidal-Puiq A, Vargas D, Gussinye M, Carrascosa A, 1998 Leptin in relation to resumption of menses in women with anorexia nervosa. Mol Psychiatry 3: 544-547.
11. Hebebrand J, Blum WF, Barth N, et al, 1997 Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol Psychiatry 2: 330-334.
12. Misra M, Miller KK, Kuo K, et al, 2005 Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 289: E373-381.
13. Modan-Moses D, Stein D, Pariente C, et al, 2007 Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. J Clin Endocrinol Metab 92: 1843-1847.
14. Delporte ML, Brichard SM, Hermans MP, Beguin C, Lambert M, 2003 Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf) 58: 22-29.
15. Pannacciulli N, Vettor R, Milan G, et al, 2003 Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab 88: 1748-1752.
16. Tagami T, Satoh N, Usui T, Yamada K, Shimatsu A, Kuzuya H, 2004 Adiponectin in anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 89: 1833-1837.
17. Wojcik MH, Meenaghan E, Lawson EA, Misra M, Klibanski A, Miller KK, 2010 Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa. Bone 46: 796-800.
18. Shiiya T, Nakazato M, Mizuta M, et al, 2002 Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87: 240-244.
19. Monteleone P, Serritella C, Martiadis V, Scognamiglio P, Maj M, 2008 Plasma obestatin, ghrelin, and ghrelin/ obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. J Clin Endocrinol Metab 93: 4418-4421.
20. Misra M, Miller KK, Kuo K, et al, 2005 Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 289: E347-356.
21. Nedvidkova J, Krykorkova I, Bartak V, et al, 2003 Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J Clin Endocrinol Metab 88: 1678-1682.
22. Utz AL, Lawson EA, Misra M, et al, 2008 Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone 43: 135-139.
23. Pfluger PT, Kampe J, Castaneda TR, et al, 2007 Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. J Clin Endocrinol Metab 92: 583-588.
24. Halmi KA, Sherman BM, 1975 Gonadotropin response to LH-RH in anorexia nervosa. Arch Gen Psychiatry 32: 875-878.
25. Sherman BM, Halmi KA, Zamudio R, 1975 LH and FSH response to gonadotropin-releasing hormone in anorexia nervosa: Effect of nutritional rehabilitation. J Clin Endocrinol Metab 41: 135-142.
26. Boyar RM, Katz J, Finkelstein JW, et al, 1974 Anorexia nervosa. Immaturity of the 24-hour luteinizing hormone secretory pattern. N Engl J Med 291: 861-865.
27. Chou SH, Chamberland JP, Liu X, et al, 2011 Leptin is an effective treatment for hypothalamic amenorrhea. Proc Natl Acad Sci USA 108: 6585-6590.
28. Köpp W, Blum WF, von Prittwitz S, et al, 1997 Low leptin levels predict amenorrhea in underweight and eating disordered females. Mol Psychiatry 2: 335-340.
29. Kluge M, Schüssler P, Schmidt D, Uhr M, Steiger A, 2012 Ghrelin suppresses secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in women. J Clin Endocrinol Metab 97: E448-451.
30. Kluge M, Schüssler P, Uhr M, Yassouridis A, Steiger A, 2007 Ghrelin suppresses secretion of luteinizing hormone in humans. J Clin Endocrinol Metab 92: 3202-3205.
31. Misra M, Katzman DK, Cord J, et al, 2008 Bone metabolism in adolescent boys with anorexia nervosa. J Clin Endocrinol Metab 93: 3029-3036.
32. Tomova A, Kumanov P, 1999 Sex differences and similarities of hormonal alterations in patients with anorexia nervosa. Andrologia 31: 143-147.
33. Miller KK, Lawson EA, Mathur V, et al, 2007 Androgens in women with anorexia nervosa and normal weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab 92: 1334-1339.
34. Estour B, Germain N, Diconne E, et al, 2010 Hormonal profile heterogeneity and short-term physical risk in restrictive anorexia nervosa. J Clin Endocrinol Metab 95: 2203-2210.
35. Gordon CM, Grace E, Emans SJ, Goodman E, Crawford MH, Leboff MS, 1999 Changes in bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa. J Bone Miner Res 14: 136-145.
36. Støving RK, Veldhuis JD, Flyvbjerg A, et al, 1999 Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: Indirect evidence for disruption of feedback regulation within the GH-Insulinlike growth factor I axis. J Clin Endocrinol Metab 84: 2056-2063.
37. Misra M, Miller KK, Bjornson J, et al, 2003 Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 88: 5615-5623.
38. De Rosa G, Corsello SM, De Rosa E, et al, 1983 Endocrine study of anorexia nervosa. Exp Clin Endocrinol 82: 160-172.
39. Masuda A, Shibasaki T, Hotta M, Suematsu H, Shizume K, 1988 Study on the mechanism of abnormal growth hormone (GH) secretion in anorexia nervosa: no evidence of involvement of a low somatomedin-C level in the abnormal GH secretion. J Endocrinol Invest 11: 297-302.
40. Argente J, Caballo N, Barrios V, et al, 1997 Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: Effect of short and long term weight recuperation. J Clin Endocrinol Metab 82: 2084-2092.
41. Hotta M, Fukuda I, Sato K, Hizuka N, Shibasaki T, Takano K, 2000 The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa. J Clin Endocrinol Metab 85: 200-206.
42. Støving RK, Chen JW, Glintborg D, et al, 2007 Bioactive insulin-like growth factor (IGF) I and IGF-binding protein-1 in anorexia nervosa. J Clin Endocrinol Metab 92: 2323-2329.
43. Fazeli PK, Lawson E, Prabhakaran R, et al, 2010 Effects of recombinant human growth hormone in anorexia nervosa: A randomized, placebo-controlled study. J Clin Endocrinol Metab 65: 4889-4897.
44. Gold PW, Gwirtsman H, Avgerinos PC, et al, 1986 Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients. N Engl J Med 314: 1335-1342.
45. Misra M, Miller KK, Almazan C, et al, 2004 Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 89: 4972-4980.
46. Lawson EA, Donoho D, Miller KK, et al, 2009 Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab 94: 4710-4716.
47. Lawson EA, Holsen LM, Desanti R, et al, 2013 Increased hypothalamic-pituitary-adrenal drive is associated with decreased appetite and hypoactivation of food motivation neurocircuitry in anorexia nervosa. Eur J Endocrinol 169: 639-647.
48. Onur S, Haas V, Bosy-Westphal A, et al, 2005 L-triiodothyronine is a major determinant of resting energy expenditure in underweight patients with anorexia nervosa and during weight gain. Eur J Endocrinol 152: 179-184.
49. Leslie RD, Isaacs AJ, Gomez J, Raggatt PR, Bayliss R, 1978 Hypothalamo-pituitary-thyroid function in anorexia nervosa: influence of weight gain. Br Med J 2: 526-528.
50. Croxson MS, Ibbertson HK, 1977 Low serum triiodothyronine (T3) and hypothyroidism in anorexia nervosa. J Clin Endocrinol Metab 44: 167-174.
51. Bannai C, Kuzuya N, Koide Y, et al, 1988 Assessment of the relationship between serum thyroid hormone levels and peripheral metabolism in patients with anorexia nervosa. Endocrinol Jpn 35: 455-462.
52. Giustina A, Mazzioti G, Canalis E, 2008 Growth hormone, insulin-like growth factors and the skeleton. Endocr Rev 29: 535-559.
53. Nussbaum M, Baird D, Sonnenblick M, Cowan K, Shenker IR, 1985 Short stature in anorexia nervosa patients. J Adolesc Health Care 6: 453-455.
54. Modan-Moses D, Yaroslavsky A, Novikov I, et al, 2003 Stunting of growth as a major feature of anorexia nervosa in male adolescents. Pediatrics 111: 270-276.
55. Modan-Moses D, Yaroslavsky A, Kochavi B, et al, 2012 Linear growth and final adult height characteristics in adolescent females with anorexia nervosa. PLoS One 7: e45504.
56. Prabhakaran R, Misra M, Miller KK, et al, 2008 Determinants of height in adolescent girls with anorexia nervosa. Pediatrics 121: e1517-1523.
57. Lantzouni E, Frank GR, Golden NH, Shenker RI, 2002 Reversibility of growth stunting in early onset anorexia nervosa: a prospective study. J Adolesc Health 31: 162-165.
58. Rozé C, Doyen C, Le Heuzey MF, Armoogum P, Mouren MC, Léger J, 2007 Predictors of late menarche and adult height in children with anorexia nervosa. Clin Endocrinol 67: 462-467.
59. Grinspoon S, Thomas E, Pitts S, et al, 2000 Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 133: 790-794.
60. Soyka LA, Grinspoon S, Levitsky LL, Herzog DB, Klibanski A, 1999 The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab 84: 4489-4496.
61. Mehler PS, Sabel AL, Watson T, Andersen AE, 2008 High risk of osteoporosis in male patients with eating disorders. Int J Eat Disord 41: 666-672.
62. Lawson EA, Miller KK, Bredella MA, et al, 2010 Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone 46: 458-463.
63. Resch H, Newrkla S, Grampp S, et al, 2000 Ultrasound and X-ray based bone densitometry in patients with anorexia nervosa. Calcif Tissue Int 66: 338-341.
64. Winston AP, Alwazeer AE, Bankart MJ, 2008 Screening for osteoporosis in anorexia nervosa: prevalence and predictors of reduced bone mineral density. Int J Eat Disord 41: 284-287.
65. Miller KK, Lee EE, Lawson EA, et al, 2006 Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 91: 2931-2937.
66. Trombetti A, Richert L, Herrmann FR, Chevalley T, Graf JD, Rizzoli R, 2013 Selective determinants of low bone mineral mass in adult women with anorexia nervosa. Int J Endocrinol 2013: 897193.
67. Biller BM, Saxe V, Herzog DB, Rosenthal DI, Holzman S, Klibanski A, 1989 Mechanisms of osteoporosis in adult women with anorexia nervosa. J Clin Endocrinol Metab 68: 548-554.
68. Misra M, Aggarwal A, Miller KK, et al, 2004 Effects of anorexia nervosa on clinical, hematologic, biochemical and bone density parameters in community-dwelling adolescent girls. Pediatrics 114: 1574-1583.
69. Bachrach LK, Guido D, Katzman D, Litt IF, Marcus R, 1990 Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics 86: 440-447.
70. Soyka LA, Misra M, Frenchman A, et al, 2002 Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 87: 4177-4185.
71. Klibanski A, Biller BMK, Schoenfeld DA, Herzog DB, Saxe VC, 1995 The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 80: 898-904.
72. Seeman E, Karlsson MK, Duan Y, 2000 On exposure to anorexia nervosa, the temporal variation in axial and appendicular skeletal development predisposes to site-specific deficits in bone size and density: a crosssectional study. J Bone Miner Res 15: 2259-2265.
73. Karlsson MK, Weigall SJ, Duan Y, Seeman E, 2000 Bone size and volumetric density in women with anorexia nervosa receiving estrogen replacement therapy and in women recovered from anorexia nervosa. J Clin Endocrinol Metab 85: 3177-3182.
74. Bredella MA, Misra M, Miller KK, et al, 2008 Distal radius in adolescent girls with anorexia nervosa: Trabecular structure analysis with High-Resolution Flat-Panel volume CT. Radiology 249: 938-946.
75. Faje AT, Karim L, Taylor A, et al, 2013 Adolescent girls with anorexia nervosa have impaired cortical and trabecular microarchitecture and lower estimated bone strength at the distal radius. J Clin Endocrinol Metab 98: 1923-1929.
76. Milos G, Spindler A, Rüegsegger P, et al, 2005 Cortical and trabecular bone density and structure in anorexia nervosa. Osteoporos Int 16: 783-790.
77. Walsh CJ, Phan CM, Misra M, et al, 2010 Women with anorexia nervosa: Finite element and trabecular structure analysis by using Flat Panel volume CT. Radiology 257: 167-174.
78. Hartman D, Crisp A, Rooney B, Rackow C, Atkinson R, Patel S, 2000 Bone density of women who have recovered from anorexia nervosa. Int J Eat Disord 28: 107-112.
79. Herzog W, Minne H, Deter C, et al, 1993 Outcome of bone mineral density in anorexia nervosa patients 11.7 years after first admission. J Bone Miner Res 8: 597-605.
80. Halvorsen I, Platou D, Høiseth A, 2012 Bone mass eight years after treatment for adolescent-onset anorexia nervosa. Eur Eat Disord Rev 20: 386-392.
81. Wentz E, Mellström D, Gillberg C, Sundh V, Gillberg IC, Råstam M, 2003 Bone density 11 years after anorexia nervosa onset in a controlled study of 39 cases. Int J Eat Disord 34: 314-318.
82. Ostrowska Z, Ziora K, Oswiecimska J, et al, 2012 RANKL/RANK/OPG system and bone status in females with anorexia nervosa. Bone 50: 156-160.
83. Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A, 1996 Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 81: 3864-3870.
84. Weinbrenner T, Zittermann A, Gouni-Berthold I, Stehle P, Berthold HK, 2003 Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control study. Eur J Clin Nutr 57: 1262-1267.
85. Lennkh C, De Zwaan M, Bailer U, et al, 1999 Osteopenia in anorexia nervosa: specific mechanisms of bone loss. J Psychiatr Res 33: 349-356.
86. Legroux-Gerot I, Vignau J, D'Herbomez M, et al, 2007 Evaluation of bone loss and its mechanisms in anorexia nervosa. Calcif Tissue Int 81: 174-182.
87. Faje AT, Fazeli PK, Katzman DK, et al, 2012 Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls. Bone 51: 474-479.
88. Misra M, Katzman DK, Clarke H, et al, 2013 Hip structural analysis in adolescent boys with anorexia nervosa and controls. J Clin Endocrinol Metab 98: 2952-2958.
89. DiVasta AD, Beck TJ, Petit MA, Feldman HA, LeBoff MS, Gordon CM, 2007 Bone cross-sectional geometry in adolescents and young women with anorexia nervosa: a hip structural analysis study. Osteoporos Int 18: 797-804.
90. Sornay-Rendu E, Boutroy S, Munoz F, Delmas PD, 2007 Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: The OFELY study. J Bone Miner Res 22: 425-433.
91. Divasta AD, Feldman HA, Gordon CM, 2013 Vertebral fracture assessment in adolescents and young women with anorexia nervosa: A Case Series. J Clin Densitom 17: 207-211.
92. Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR, 1991 The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA 265: 1133-1138.
93. Lucas RA, Melton J, Crowson CS, O'Fallon WM, 1999 Long-term fracture risk among women with anorexia nervosa: A population-based cohort study. Mayo Clin Proc 74: 972-977.
94. Vestergaard P, Emborg C, Støving RK, Hagen C, Mosekilde L, Brixen K, 2002 Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders-a nationwide register study. Int J Eat Disord 32: 301-308.
95. Chow J, Tobias JH, Colston KW, Chambers TJ, 1992 Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J Clin Invest 89: 74-78.
96. Majeska RJ, Ryaby JT, Einhorn TA, 1994 Direct modulation of osteoblastic activity with estrogen. J Bone Joint Surg Am 76: 713-721.
97. Qu Q, Perälä-Heape M, Kapanen A, et al, 1998 Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone 22: 201-209.
98. Ferrari S, Bianchi ML, Eisman JA, et al; IOF Committee of Scientific Advisors Working Group on Osteoporosis Pathophysiology, 2012, Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int 23: 2735-2748.
99. Grinspoon S, Miller K, Coyle C, et al, 1999 Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab 84: 2049-2055.
100. Kasperk C, Fitzsimmons R, Strong D, 1990 Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells. J Clin Endocrinol Metab 71: 1322-1329.
101. O'Brien CA, Jia D, Plotkin LI, et al, 2004 Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145: 1835-1841.
102. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC, 1998 Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102: 274-282.
103. Jia D, O'Brien CA, Stewart SA, Manolagas SC, Weinstein RS, 2006 Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 147: 5592-5599.
104. Dekkers OM, Horváth-Puhó E, Jørgensen JO, et al, 2013 Multisystem morbidity and mortality in Cushing's syndrome: a cohort study. J Clin Endocrinol Metab 98: 2277-2284.
105. van Staa TP, Leufkens HG, Cooper C, 2002 The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13: 777-787.
106. McCarthy TL, Centrella M, Canalis E, 1989 Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 124: 301-309.
107. Sims NA, Clément-Lacroix P, Da Ponte F, et al, 2000 Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest 106: 1095-1103
108. Pereira RC, Jorgetti V, Canalis E, 1999 Triiodothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts. Am J Physiol 277: E496-504.
109. Gouveia CH, Schultz JJ, Bianco AC, Brent GA, 2001 Thyroid hormone stimulation of osteocalcin gene expression in ROS 17/2.8 cells is mediated by transcriptional and post-transcriptional mechanisms. J Endocrinol 170: 667-675.
110. Varga F, Rumpler M, Zoehrer R, et al, 2010 T3 affects expression of collagen I and collagen cross-linking in bone cell cultures. Biochem Biophys Res Commun 402: 180-185.
111. Eriksen EF, Mosekilde L, Melsen F, 1986 Kinetics of trabecular bone resorption and formation in hypothyroidism: evidence for a positive balance per remodeling cycle. Bone 7: 101-108.
112. Vestergaard P, Mosekilde L, 2002 Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid 12: 411-419.
113. Vestergaard P, Rejnmark L, Mosekilde L, 2005 Influence of hyper-and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int 77: 139-144.
114. Ravn P, Cizza G, Bjarnason NH, et al, 1999 Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. J Bone Miner Res 14: 1622-1627.
115. De Laet C, Kanis JA, Odén A, et al, 2005 Body mass index as a predictor of fracture risk: A meta-analysis. Osteoporos Int 16: 1330-1338.
116. Dalsky GP, Stocke KS, Ehsani AA, Slatopolsky E, Lee WC, Birge SJ Jr 1988 Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women. Ann Intern Med 108: 824-828.
117. Snow CM, Williams DP, LaRiviere J, Fuchs RK, Robinson TL, 2001 Bone gains and losses follow seasonal training and detraining in gymnasts. Calcif Tissue Int 69: 7-12.
118. Pettersson U, Nordström P, Alfredson H, Henriksson-Larsén K, Lorentzon R, 2000 Effect of high impact activity on bone mass and size in adolescent females: A comparative study between two different types of sports. Calcif Tissue Int 67: 207-214.
119. Zerwekh JE, Ruml LA, Gottschalk F, Pak CY, 1998 The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res 13: 1594-601.
120. Leblanc AD, Schneider VS, Evans HJ, Engelbretson DA, Krebs JM, 1990 Bone mineral loss and recovery after 17 weeks of bed rest. J Bone Miner Res 5: 843-850.
121. Ellman R, Spatz J, Cloutier A, Palme R, Christiansen BA, Bouxsein ML, 2013 Partial reductions in mechanical loading yield proportional changes in bone density, bone architecture, and muscle mass. J Bone Miner Res 28: 875-885.
122. Fleischer J, Stein EM, Bessler M, et al, 2008 The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab 93: 3735-3740.
123. Vilarrasa N, Gómez JM, Elio I, et al, 2009 Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss. Obes Surg 19: 860-866.
124. Tatsumi S, Ishii K, Amizuka N, et al, 2007 Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab 5: 464-475.
125. Aguirre JI, Plotkin LI, Stewart SA, et al, 2006 Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J Bone Miner Res 21: 605-615.
126. Bonewald LF, Johnson ML, 2008 Osteocytes, mechanosensing and Wnt signaling. Bone 42: 606-615.
127. Lin C, Jiang X, Dai Z, et al, 2009 Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J Bone Miner Res 24: 651-1661.
128. Spatz JM, Ellman R, Cloutier AM, et al, 2013 Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading. J Bone Miner Res 28: 865-874.
129. Gaudio A, Pennisi P, Bratengeier C, et al, 2010 Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 95: 2248-2253.
130. Spatz JM, Fields EE, Yu EW, et al, 2012 Serum sclerostin increases in healthy adult men during bed rest. J Clin Endocrinol Metab 97: E1736-1740.
131. Armamento-Villareal R, Sadler C, Napoli N, et al, 2012 Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training. J Bone Miner Res 27: 1215-1221.
132. Kooh SW, Noriega E, Leslie K, Müller C, Harrison JE, 1996 Bone mass and soft tissue composition in adolescents with anorexia nervosa. Bone 19: 181-188.
133. Kosmiski L, Schmiege SJ, Mascolo M, Gaudiani J, Mehler PS, 2013 Chronic starvation secondary to anorexia nervosa is associated with an adaptive suppression of resting energy expenditure. J Clin Endocrinol Metab [DOI: http://dx.doi.org/10.1210/jc.2013-1694]
134. Haas VK, Kohn MR, Clarke SD, et al, 2009 Body composition changes in female adolescents with anorexia nervosa. Am J Clin Nutr 89: 1005-1010.
135. McLoughlin DM, Spargo E, Wassif WS, et al, 1998 Structural and functional changes in skeletal muscle in anorexia nervosa. Acta Neuropathol 95: 632-640.
136. Essén B, Fohlin L, Thorén C, Saltin B, 1981 Skeletal muscle fibre types and sizes in anorexia nervosa patients. Clin Physiol 1: 395-403.
137. Lindboe CF, Askevold F, Slettebø M, 1982 Changes in skeletal muscles of young women with anorexia nervosa. An enzyme histochemical study. Acta Neuropathol 56: 299-302.
138. Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL, 1999 Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140: 1630-1638.
139. Cornish J, Callon KE, Bava U, et al, 2002 Leptin directly stimulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175: 405-415.
140. Ducy P, Amling M, Takeda S, et al, 2000 Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100: 197-207.
141. Pasco JA, Henry MJ, Kotowicz MA, et al, 2001 Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab 86: 1884-1887.
142. Yamauchi M, Sugimoto T, Yamaguchi T, et al, 2001 Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol 55: 341-347.
143. Ruhl CE, Everhart JE, 2002 Relationship of serum leptin concentrations with bone mineral density in the United States population. J Bone Miner Res 17: 1896-1903.
144. Odabaşi E, Ozata M, Turan M, et al, 2000 Plasma leptin concentrations in postmenopausal women with osteoporosis. Eur J Endocrinol 142: 170-173.
145. Berner HS, Lyngstadaas SP, Spahr A, et al, 2004 Adiponectin and its receptors are expressed in boneforming cells. Bone 35: 842-849.
146. Shinoda Y, Yamaguchi M, Ogata N, et al, 2006 Regulation of bone formation by adiponectin through autocrine/ paracrine and endocrine pathways. J Cell Biochem 99: 196-208.
147. Oshima K, Nampei A, Matsuda M, et al, 2005 Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 331: 520-526.
148. Biver E, Salliot C, Combescure C, et al, 2011 Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab 96: 2703-2713.
149. Misra M, Miller KK, Cord J, et al, 2007 Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab 92: 2046-2052.
150. Baldock PA, Sainsbury A, Couzens M, et al, 2002 Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109: 915-921.
151. Baldock PA, Lee NJ, Driessler F, et al, 2009 Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight. PLoS One 4: e8415.
152. Wong IP, Nguyen AD, Khor EC, et al, 2013 Neuropeptide Y is a critical modulator of leptin's regulation of cortical bone. J Bone Miner Res 28: 886-898.
153. Wortley KE, Garcia K, Okamoto H, et al, 2007 Peptide YY regulates bone turnover in rodents. Gastroenterology 133: 1534-1543.
154. Wong IP, Driessler F, Khor EC, et al, 2012 Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology. PLoS One 7: e40038.
155. Misra M, Miller KK, Tsai P, et al, 2006 Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 91: 1027-1033.
156. Cornish J, Callon KE, Cooper GJ, Reid IR, 1995 Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochem Biophys Res Commun 207: 133-139.
157. Cornish J, Callon KE, Bava U, Kamona SA, Cooper GJ, Reid IR, 2001 Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone 29: 162-168.
158. Cornish J, Callon KE, King AR, Cooper GJ, Reid IR, 1998 Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice. Am J Physiol 275: E694-699.
159. Bollag RJ, Zhong Q, Phillips P, et al, 2000 Osteoblastderived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology 141: 1228-1235.
160. Xie D, Cheng H, Hamrick M, et al, 2005 Glucosedependent insulinotropic polypeptide receptor knockout mice have altered bone turnover. Bone 37: 759-769.
161. Bollag RJ, Zhong Q, Ding KH, et al, 2001 Glucosedependent insulinotropic peptide is an integrative hormone with osteotropic effects. Mol Cell Endocrinol 177: 35-41.
162. Maccarinelli G, Sibilia V, Torsello A, et al, 2005 Ghrelin regulates proliferation and differentiation of osteoblastic cells. J Endocrinol 184: 249-256.
163. Fukushima N, Hanada R, Teranishi H, et al, 2005 Ghrelin directly regulates bone formation. J Bone Miner Res 20: 790-798.
164. Sun Y, Ahmed S, Smith RG, 2003 Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23: 7973-7981.
165. Misra M, Miller KK, Stewart V, et al, 2005 Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab 90: 5082-5087.
166. Fazeli PK, Galder GL, Miller KK, et al, 2012 Psychotropic medication use in anorexia nervosa between 1997 and 2009. Int J Eat Disord 45: 970-976.
167. Diem SJ, Blackwell TL, Stone KL, et al, 2007 Use of antidepressants and rates of hip bone loss in elderly women: the study of osteoporotic fractures. Arch Intern Med 167: 1240-1245.
168. Haney EM, Chan BK, Diem SJ, et al, Osteoporotic Fractures in Men Study Group 2007 Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 167: 1246-1251.
169. Richards JB, Papaioannou A, Adachi JD, et al, Canadian Multicentre Osteoporosis Study Research Group 2007 Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 167: 188-194.
170. Weintrob N, Cohen D, Klipper-Aurbach Y, Zadik Z, Dickerman Z, 2002 Decreased growth during therapy with selective serotonin reuptake inhibitors. Arch Pediatr Adolesc Med 156: 696-701.
171. Warden SJ, Robling AG, Sanders MS, Bliziotes MM, Turner CH, 2005 Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 146: 685-693.
172. Ross AC, Manson JE, Abrams SA, et al, 2011 The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab 96: 53-58.
173. Miller KK, Grinspoon SK, Ciampa J, Hier J, Herzog D, Klibanski A, 2005 Medical findings in outpatients with anorexia nervosa. Arch Intern Med 165: 561-566.
174. Haagensen AL, Feldman HA, Ringelheim J, Gordon CM, 2008 Low prevalence of vitamin D deficiency among adolescents with anorexia nervosa. Osteoporos Int 19: 289-294.
175. Morgan JF, Bolton J, Sedgwick PM, Patel S, Lacey JH, Conway GS, 1999 Changes in plasma concentrations of leptin and body fat composition during weight restoration in anorexia nervosa. J Clin Endocrinol Metab 84: 2257.
176. Bolton JG, Patel S, Lacey JH, White S, 2005 A prospective study of changes in bone turnover and bone density associated with regaining weight in women with anorexia nervosa. Osteoporos Int 16: 1955-1962.
177. Dominguez J, Goodman L, Sen Gupta S, et al, 2007 Treatment of anorexia nervosa is associated with increases in bone mineral density, and recovery is a biphasic process involving both nutrition and return of menses. Am J Clin Nutr 86: 92-99.
178. Counts DR, Gwirtsman H, Carlsson LM, Lesem M, Cutler GB, 1992 The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab 75: 762-767.
179. Viapiana O, Gati D, Dalle Grave R, et al, 2007 Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight. Bone 40: 1073-1077.
180. Augusseau AC, Lafage-Proust MH, Margaillan P, et al, 2000 Weight gain reverses bone turnover and restores circadian variation of bone resoption in anorexic patients. Clin Endocrinol 52: 113-121.
181. Heer M, Mika C, Grzella I, Drummer C, Herpertz-Dahlmann B, 2002 Changes in bone turnover in patients with anorexia nervosa during eleven weeks of inpatient dietary treatment. Clin Chem 48: 754-760.
182. Compston JE, McConachie C, Stott C, et al, 2006 Changes in bone mineral density, body composition and biochemical markers of bone turnover during weight gain in adolescents with severe anorexia nervosa: a 1-year prospective study. Osteoporos Int 17: 77-84.
183. Milos G, Spindler A, Rüegsegger P, et al, 2007 Does weight gain induce cortical and trabecular bone regain in anorexia nervosa? A two-year prospective study. Bone 41: 869-874.
184. García-De Alvaro MT, Muñoz-Calvo MT, Martínez G, Barrios V, Hawkins F, Argente J, 2007 Regional skeletal bone deficit in female adolescents with anorexia nervosa: influence of the degree of malnutrition and weight recovery in a two year longitudinal study. J Pediatr Endocrinol Metab 20: 1223-1231.
185. Misra M, Prabhakaran R, Miller KK, et al, 2008 Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 93: 1231-1237.
186. Seeman E, Szmukler GI, Formica C, Tsalamandris C, Mestrovic R, 1992 Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise. J Bone Miner Res 7: 1467-1474.
187. Gordon CM, Goodman E, Emans SJ, et al, 2002 Physiologic regulators of bone turnover in young women with anorexia nervosa. J Pediatr 141: 64-70.
188. Diamanti A, Bizzarri C, Gambarara M, et al, 2007 Bone mineral density in adolescent girls with early onset of anorexia nervosa. Clin Nutr 26: 329-334.
189. Hay PJ, Delahunt JW, Hall A, Mitchell AW, Harper G, Salmond C, 1992 Predictors of osteopenia in premenopausal women with anorexia nervosa. Calcif Tissue Int 50: 498-501.
190. Joyce JM, Warren DL, Humphries LL, Smith AJ, Coon JS, 1990 Osteoporosis in women with eating disorders: comparison of physical parameters, exercise, and menstrual status with SPA and DPA evaluation. J Nucl Med 31: 325-331.
191. Waugh EJ, Woodside DB, Beaton DE, Coté P, Hawker GA, 2011 Effects of exercise on bone mass in young women with anorexia nervosa. Med Sci Sports Exerc 43: 755-763.
192. Legroux-Gerot I, Vignau J, Collier F, Cortet B, 2008 Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy. Calcif Tissue Int 83: 315-323.
193. Muñoz MT, Morandé G, García-Centenera JA, Hervás F, Pozo J, Argente J, 2002 The effects of estrogen administration on bone mineral density in adolescents with anorexia nervosa. Eur J Endocrinol 146: 45-50.
194. Golden NH, Lanzkowsky L, Schebendach J, Palestro CJ, Jacobson MS, Shenker R, 2002 The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol 15: 135-143.
195. Strokosch GR, Friedman AJ, Wu SC, Kamin M, 2006 Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebocontrolled study. J Adolesc Health 39: 819-827.
196. Misra M, Katzman D, Miller KK, et al, 2011 Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res 26: 2430-2438.
197. Bloch M, Ish-Shalom S, Greenman Y, Klein E, Latzer Y, 2012 Dehydroepiandrosterone treatment effects on weight, bone density, bone metabolism and mood in women suffering from anorexia nervosa-a pilot study. Psychiatry Res 200: 544-549.
198. Gordon CM, Grace E, Emans SJ, et al, 2002 Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: A randomized trial. J Clin Endocrinol Metab 87: 4935-4941.
199. DiVasta AD, Feldman HA, Giancaterino C, Rosen CJ, LeBoff MS, Gordon CM, 2012 The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa. Metabolism 61: 1010-1020.
200. Divasta AD, Feldman HA, Beck TJ, Leboff MS, Gordon CM, 2013 Does hormone replacement normalize bone geometry in adolescents with anorexia nervosa? J Bone Miner Res 29: 151-157.
201. Nakahara T, Nagai N, Tanaka M, et al, 2006 The effects of bone therapy on tibial bone loss in young women with anorexia nervosa. Int J Eat Disord 39: 20-26.
202. Golden NH, Iglesias EA, Jacobson MS, et al, 2005 Alendronate for the treatment of osteopenia in anorexia nervosa: A randomized, double-blind, placebocontrolled trial. J Clin Endocrinol Metab 90: 3179-3185.
203. Miller KK, Griego KA, Mulder J, et al, 2004 Effects of risedronate on bone density in anorexia nervosa. J Clin Endocrinol Metab 89: 3903-3906.
204. Miller KK, Meenaghan E, Lawson EA, et al, 2011 Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: A randomized, placebo-controlled study. J Clin Endocrinol Metab 96: 2081-2088.
205. Misra M, McGrane J, Miller KK, et al, 2009 Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. Bone 45: 493-498.
206. Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A, 2002 Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 87: 2883-2891.
207. Iketani T, Kiriike N, Murray, et al, 2003 Effect of menatetrenone (vitamin K2) treatment on bone loss in patients with anorexia nervosa. Psychiatry Res 117: 259-269.
208. http://clinicaltrials.gov/, assessed at 22/10/2013.